Goalattainment following upper-limb botulinum toxin-A injections: Are we facilitating achievement of client-centred goals?

Journal of Rehabilitation Medicine

Volumn 46, Issue 9, 2014, Pages 864-868

  Nott, Melissa T ^a   Barden, Hannah L H ^b,c   Baguley, Ian J ^b,d  

^a CHARLES STURT UNIVERSITY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Botulinum; Brain injuries; Muscle spasticity; Stroke; Toxins; Upper extremity

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; ARM; COMPLICATION; DAILY LIFE ACTIVITY; DISABILITY; FEMALE; HUMAN; INJECTION; MALE; MOTIVATION; MUSCLE SPASTICITY; PATHOPHYSIOLOGY; STROKE; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; BOTULINUM TOXINS, TYPE A; DISABILITY EVALUATION; FEMALE; GOALS; HUMANS; INJECTIONS; MALE; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; STROKE; TREATMENT OUTCOME; UPPER EXTREMITY;

EID: 84921815919     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-1853     Document Type: Review

References (27)

1. Pandyan AD, Gregoric M, Barnes MP, Wood D, Van Wijck F, Burridge J, et al. Spasticity: Clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil 2005; 27: 2-6.
2. Barnes MP. An overview of the clinical management of spasticity. In: Barnes MP and Johnson GR, editors. Upper motor neurone syndrome and spasticity: clinical management and neurophysiology. New York: Cambridge University Press; 2008, p. 1-8.
3. Sunnerhagen KS, Olver J, Francisco GE. Assessing and treating functional impairment in poststroke spasticity. Neurol 2013; 80 Suppl 2: S35-S44.
4. Sheean G1, Lannin NA, Turner-Stokes L, Rawicki B, Snow BJ; Cerebral Palsy Institute. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement. Eur J Neurol 2010; 17 Suppl 2: 74-93.
5. Francis HP, Wade DT, Turner-Stokes L, Kingswell RS, Dott CS, Coxon EA. Does reducing spasticity translate into functional benefit? An exploratory meta-analysis. J Neurol Neurosurg Psych 2004; 75: 1547-1551.
6. Meythaler JM, Vogtle L, Brunner RC. A preliminary assessment of the benefits of the addition of botulinum toxin A to a conventional therapy program on the function of people with longstanding stroke. Arch Phys Med Rehabil 2009; 90: 1453-1461.
7. Shaw LC, Price CI, van Wijck FM, Shackley P, Steen N, Barnes MP, et al. Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain. Stroke 2011; 42: 1371-1379.
8. Kelley RE, Borazanci AP. Stroke rehabilitation. Neurol Res 2009; 31: 832-840.
9. Williams G, Olver J, de Graaff S, Singer BJ. The use of botulinum toxin type A in the management of adult-onset focal spasticity: a survey of Australian allied health professionals. Aust Occ Ther J 2012; 59: 257-264.
10. Ashford S, Turner-Stokes L. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes. Disabil Rehabil 2009; 31: 220-226.
11. Bakheit AM, Zakine B, Maisonobe P, Aymard C, Fhedoroff K, Hefter H., et al. The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey. Int J Rehabil Res 2010; 33: 199-204.
12. Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Davies L, McCrory P, et al. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial. J Rehabil Med 2010; 42: 81-89.
13. Preston N, Clarke M, Bhakta B. Development of a framework to define the functional goals and outcomes of botulinum toxin a spasticity treatment relevant to the child and family living with cerebral palsy using the International classification of Functioning, Disability and Health for children and youth. J Rehabil Med 2011; 43: 1010-1015.
14. Kiresuk TJ, Sherman RE. Goal attainment scaling: A general method for evaluating comprehensive community mental health programs. Community Ment Health J 1968; 4: 443-453.
15. Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation: a practical guide. Clin Rehabil 2009; 23: 362-370.
16. Ashford S, Turner-Stokes L. Goal attainment for spasticity management using botulinum toxin. Physiotherapy Res Int 2006; 11: 24-34.
17. Bohannon RW, Smith MB. Interrater reliability of a Modified Ashworth Scale of muscle spasticity. Phys Ther 1987; 67: 206-207.
18. Tardieu G, Shentoub S, Delarue R. A la recherche d'une technique de mesure de la spasticité. Revue de Neurologie 1954; 91: 143-144.
19. Platz T, Pinkowski C, van Wijck F, Johnson GRJ. ARM-Arm Rehabilitation Measurement: Manual for performance and scoring of the Fugl-Meyer test (arm section), Action Research Arm test, and the Boxand- Block test. Deutscher Wissenschafts-Verlag: Baden-Baden; 2005.
20. Cieza A, Brockow T, Ewert T, Amman E, Kollerits B, Chatterji S, et al. Linking health-status measurements to the international classification of functioning, disability and health. J Rehabil Med 2002; 34: 205-210.
21. Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustün B, Stucki G. ICF linking rules: an update based on lessons learned. J Rehabil Med 2005; 37: 212-218.
22. Corder GW, Foreman DI. Nonparametric statistics for non-statisticians: A step-by-step approach. Hoboken: John Wiley and Sons Inc; 2009.
23. Portney LG, Watkins MP. Foundations of clinical research: Applications to practice. 3 ed. Upper Saddle River: Pearson/Prentice Hall; 2009.
24. Rosales RL, Kanovsky P, Fernandez HH. What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications. Parkinsonism Relat D 2011; 17 Suppl 1: S3-S10.
25. Chang CL, Munin MC, Skidmore ER, Niyonkuru C, Huber LM, Weber DJ. Effect of baseline spastic hemiparesis on recovery of upper-limb function following botulinum toxin type A injections and postinjection therapy. Arch Phys Med Rehabil 2009; 90: 1462-1468.
26. Hefter H, Jost WH, Reissig A, Zakine B, Bakheit AM, Wissel J. Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment? Int J Rehabil Res 2012; 35: 227-233.
27. Baguley IJ, Nott MT, Turner-Stokes L, De Graaff S, Katrak P, McCrory P, et al. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity. J Rehabil Med 2011; 43: 1032-1037.